Comparison of 4 different Hepatitis B vaccines in healthy persons in whom a standard hepatitis B vaccination schedule of three vaccinations did not induces a protective immune response, so-called non-responders.
Phase of Trial: Phase IV
Latest Information Update: 10 Oct 2016
At a glance
- Drugs Hepatitis A-hepatitis B vaccine (Primary) ; Hepatitis B vaccine recombinant (Primary) ; Hepatitis B vaccine recombinant (HBvaxPro) (Primary)
- Indications Hepatitis A; Hepatitis B
- Focus Pharmacodynamics
- Acronyms RESPONS; RESPONSE
- 07 Oct 2016 Planned End Date changed from 1 Mar 2013 to 1 Sep 2017.
- 02 Oct 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2011-005627-40).
- 19 Sep 2012 Status changed from planning to recruiting as reported by EudraCT.